dc.contributor.author | Dell'Accio, F | en_US |
dc.contributor.author | Cailotto, F | en_US |
dc.date.accessioned | 2018-01-16T09:52:38Z | |
dc.date.available | 2017-10-18 | en_US |
dc.date.issued | 2018-01 | en_US |
dc.date.submitted | 2017-10-18T09:09:16.534Z | |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/31328 | |
dc.format.extent | 4 - 6 | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Osteoarthritis Cartilage | en_US |
dc.rights | © 2017. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | Wnt Proteins | en_US |
dc.subject | Wnt Signaling Pathway | en_US |
dc.subject | beta Catenin | en_US |
dc.title | Pharmacological blockade of the WNT-beta-catenin signaling: a possible first-in-kind DMOAD. | en_US |
dc.type | Article | |
dc.rights.holder | © 2017 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved. | |
dc.identifier.doi | 10.1016/j.joca.2017.10.014 | en_US |
pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/29079516 | en_US |
pubs.issue | 1 | en_US |
pubs.notes | No embargo | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 26 | en_US |
dcterms.dateAccepted | 2017-10-17 | en_US |
qmul.funder | Targeting WNT/CaMKII in Osteoarthritis::MRC | en_US |
qmul.funder | Targeting WNT/CaMKII in Osteoarthritis::MRC | en_US |
qmul.funder | Targeting WNT/CaMKII in Osteoarthritis::MRC | en_US |